Document is current
Any future updates will be listed below
-
Authors
Dehdab, Reza
Afat, Saif
Mankertz, Fiona
Brendel, Jan Michael
Maalouf, Nour
Werner, Sebastian
Brendlin, Andreas
Herrmann, Judith
Nikolaou, Konstantin
Kloker, Linus D.
Calukovic, Branko
Benzler, Katrin
Zender, Lars
Deinzer, Christoph K. W.
-
Funding
Funding for this research was provided by:
Eberhard Karls Universität Tübingen
- License Information
-
More Information
Article History
Received: 1 December 2025
Accepted: 19 January 2026
First Online: 27 February 2026
Declarations
:
: Christoph K. W. Deinzer is a consulting or advisory board member for Boehringer Ingelheim Pharma. He has received lecture honoraria from PharmaMar. In addition, he has accepted imbursement for travel, accommodation or congress registration expenses from Boehringer Ingelheim Pharma, Deciphera Pharmaceuticals, Lilly, Sanofi and Pierre Fabre Pharma all outside the submitted work. Katrin Benzler has accepted imbursement for travel, accommodation or congress registration expenses from Boehringer Ingelheim Pharma, Pierre Fabre Pharma and Lilly Pharma all outside the submitted work. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
